Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?

Allogeneic stem cell transplantation (allo-SCT) represented the first immunotherapy to treat hematologic malignancies: it has been considered as a cure for the disease and never as an approach to extend the life of patients. The success of allo-SCT derives both from the ability to treat patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Martino, Massimo, Canale, Filippo Antonio, Naso, Virginia, Porto, Gaetana, Gerace, Demetrio, Allegra, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861434/
https://www.ncbi.nlm.nih.gov/pubmed/36674573
http://dx.doi.org/10.3390/ijms24021045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861434/
https://www.ncbi.nlm.nih.gov/pubmed/36674573
http://dx.doi.org/10.3390/ijms24021045

Ejemplares similares